The Virtual NP Weight Loss and Urgent Care

The Virtual NP Weight Loss and Urgent Care operates as a telehealth practice serving patients across Texas, Florida, New York, Arizona, Nevada, New Mexico, and Kansas, with a clinical focus on weight management through peptide therapy, men's health optimization, and virtual urgent care services. Founded and directed by Sandra Jordan, MSN, APRN, FNP-C, a board-certified family nurse practitioner based in Houston, TX, the practice delivers prescription weight loss interventions and acute care consultations through HIPAA-compliant video platforms. The clinic's multi-state licensure allows Jordan to treat patients remotely while maintaining continuity of care across state lines, a model designed for individuals seeking medical weight loss without geographic barriers.

The Virtual NP's weight loss protocols center on three FDA-approved GLP-1 receptor agonist peptides: semaglutide, tirzepatide, and liraglutide. Semaglutide is prescribed for patients requiring once-weekly subcutaneous injections to reduce appetite and slow gastric emptying, with dosing titrated based on individual tolerance and weight loss response. Tirzepatide, a dual GIP/GLP-1 receptor agonist, is offered for patients who may benefit from enhanced glycemic control alongside weight reduction, particularly those with metabolic syndrome or prediabetes. Liraglutide serves as a daily injection alternative for patients preferring more frequent dosing or those transitioning from other weight management regimens. Each peptide therapy plan includes baseline metabolic assessments, medication education, injection technique training via telehealth, and scheduled follow-up appointments to monitor progress, adjust dosing, and address side effects such as nausea or gastrointestinal discomfort.

Sandra Jordan brings board certification in family practice to her telehealth consultations, applying her clinical training to both chronic weight management and acute episodic care. Her approach to peptide-based weight loss involves initial virtual consultations that include review of medical history, current medications, weight loss goals, and contraindications to GLP-1 therapy such as personal or family history of medullary thyroid carcinoma. Jordan evaluates patients for appropriateness of each peptide option based on BMI, comorbid conditions, insurance coverage, and patient preference for injection frequency. For men's health concerns, the practice addresses conditions including erectile dysfunction, low testosterone symptoms, and metabolic health optimization, often integrating weight loss peptides into broader hormone and metabolic treatment plans. The urgent care component provides virtual evaluation and treatment for non-emergency conditions such as respiratory infections, urinary symptoms, skin conditions, and minor injuries, with electronic prescribing to local pharmacies when indicated.

Patients initiating care with The Virtual NP complete an online intake form and schedule a video consultation through the clinic's patient portal. During the initial telehealth visit, Jordan conducts a clinical interview, reviews any recent laboratory work or requests new metabolic panels if needed, and discusses realistic weight loss timelines and expectations for peptide therapy. Patients approved for semaglutide, tirzepatide, or liraglutide receive prescriptions sent to their preferred pharmacy, along with detailed injection instructions and a titration schedule. Follow-up appointments occur every four to six weeks during the active weight loss phase, with Jordan adjusting peptide doses based on reported side effects, weight trends, and patient tolerance. The virtual format eliminates travel time to a physical clinic, allowing patients across the seven-state service area to access prescription weight loss care from home or work. Urgent care visits are available for established patients experiencing acute illnesses, providing same-day or next-day video consultations for conditions that do not require in-person examination or imaging.

The Virtual NP differentiates itself through its multi-state telehealth infrastructure, enabling Sandra Jordan to maintain active nurse practitioner licenses in Texas, Florida, New York, Arizona, Nevada, New Mexico, and Kansas. This licensure portfolio allows the practice to serve patients who relocate, travel frequently, or live in areas with limited access to peptide therapy providers. The clinic's integration of weight loss, men's health, and urgent care under one virtual practice creates continuity for patients managing multiple health concerns, reducing the need to coordinate care across separate providers. Prescriptions for semaglutide, tirzepatide, and liraglutide are sent electronically to pharmacies within each patient's state, and Jordan provides guidance on prior authorization processes, compounding pharmacy options when brand-name medications are cost-prohibitive, and strategies for managing common GLP-1 side effects. The Houston-based practice operates with flexible scheduling to accommodate patients in different time zones, offering evening and weekend appointment availability for working professionals and those with scheduling constraints that make traditional office visits difficult.